
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates

Healthcare providers rely heavily on POC glucose meter accuracy to guide critical bedside decisions. However, a recent study involving large inpatient cohorts from Australia and the United States suggests that real-world performance often diverges from manufacturer claims. Researchers analyzed retrospective data to compare point-of-care (POC) devices against laboratory and blood gas methods. The results indicate that systematic biases exist within routine hospital settings, particularly during extremes of glycaemia.
The study found that POC meters frequently exhibit a predictable pattern of error. Specifically, these devices showed a positive bias at lower glucose levels and a negative bias at higher concentrations. While most results remained within clinically "safe" zones on standard error grids, they often failed to meet strict ISO or FDA numerical targets. Consequently, clinicians should interpret POC results with caution when they fall outside normal ranges. Furthermore, blood gas measurements proved to be a much more reliable practical comparator to laboratory gold standards than handheld meters.
One of the most significant findings involves the influence of physiological variables. The research highlighted that low haemoglobin levels significantly amplify negative bias at higher glucose stages. Because anaemia is prevalent among hospitalised patients, this discovery has direct implications for inpatient management. In addition, variations in partial pressure of oxygen (pO2) did not show a consistent impact on meter performance. Therefore, clinicians must consider a patient's haematocrit level when evaluating suspicious glucose readings.
To improve patient safety, hospitals should implement local validation protocols for their glucose monitoring systems. If a POC result seems inconsistent with a patient's clinical presentation, the staff must perform confirmatory laboratory testing. Moreover, narrowing the time window between POC and lab measurements can help identify these discrepancies more effectively. By recognizing the limitations of bedside technology, medical teams can better avoid potential dosing errors and improve overall glycaemic control.
Low haemoglobin or haematocrit levels can cause a negative bias in many POC glucose meters, especially at high blood sugar levels. This means the meter might show a lower result than the actual laboratory glucose concentration.
Yes, the study indicated that blood gas measurements closely parallel laboratory gold standards. Therefore, they serve as a more reliable practical alternative for monitoring critically ill patients compared to standard handheld POC meters.
You should always verify suspicious or extreme POC results with a formal laboratory glucose test. This step is crucial for ensuring accurate diagnosis and preventing inappropriate insulin or glucose administration.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Cooper JAL et al. Real-world performance of point-of-care metre, blood gas and laboratory glucose methods in Australian and American hospital inpatient cohorts. Diabet Med. 2026 Jun 17. doi: 10.1111/dme.70395. PMID: 42310492.
Mishra K et al. Accuracy of point-of-care capillary blood sugar measurements in critically ill patients: An observational study. Int J Crit Illn Inj Sci. 2024 Apr-Jun;14(2):74-78.
Tang Z et al. Validation of Point-of-Care Blood Glucose Monitoring Systems in Hospital Settings. Association for Diagnostics & Laboratory Medicine (ADLM). 2022.

A large-scale retrospective study reveals systematic biases in POC glucose meters compared to laboratory methods. Findings show that anaemia significantly amplifies negative bias at high glucose levels, suggesting a need for confirmatory testing in high-risk inpatient scenarios.
Yesterday

With experts warning of an El Niño-induced rise in monsoon infections, Maharashtra has ordered intensive disease surveillance and preventative actions. Healthcare systems are enhancing laboratory resources and monitoring larval sources to control mosquito-borne outbreaks like dengue and chikungunya.
Today

A study confirms that short-course preoperative endocrine therapy significantly reduces Ki67 levels in ER-positive breast cancer, with the MammaPrint assay acting as a key predictor of this functional response.
Today

Researchers have developed a recyclable, high-strength chitosan-based conductive hydrogel. It enables high-fidelity monitoring of ECG, EMG, and EEG signals, offering a sustainable and sensitive solution for early-stage disease screening and multifunctional human motion sensing.
Today

Restoring load-bearing connective tissues remains a challenge in regenerative medicine. This review explores how biomass-derived hydrogels, enhanced by AI and innovative reinforcement strategies, are paving the way for next-generation clinical scaffolds in orthopedics and surgery.
Today

Researchers have developed a modular PEG-based scaffold that simplifies the creation of multi-agonist peptide therapeutics. Using GLP-1 and amylin agonists as a model, this platform enables rapid, modular assembly of potent multi-receptor drugs, offering a new route for treating obesity and metabolic diseases.
Today